Vietnam MoH, Draft Regulations on Cosmetics Announced

On October 2, 2026, Vietnam’s Ministry of Health(MoH) notified the World Trade Organization (WTO) of a draft Decree on the Management of Cosmetics. This comprehensive draft, consisting of 10 chapters and 60 articles, introduces significant changes to the regulatory framework governing the production, notification, import, export, and circulation of cosmetics in Vietnam.Compared with the current ..

Brazil ANVISA, Brazil ANVISA: Draft Regulation on the Classification and Registration of Single-Use and Reusable Medical Devices

On September 24, 2026, the Brazilian National Health Surveillance Agency (ANVISA) proposed Public Consultation No. 1423 regarding the classification and registration of single-use and reusable medical devices. The purpose of this proposal is to establish new regulations setting forth the requirements for classifying and registering medical devices as single-use or reusable, including labeling an..

On October 8, 2026, China’s National Medical Products Administration (NMPA) issued the Announcement on Matters Concerning the Implementation of the Revised Contents of the Safety and Technical Standards (STSC) for Comsetics. Addressing the catalogs of prohibited/restricted and permitted ingredients of cosmetics (including toothpaste), the microbiological and harmful substance limits, and the tes..

On September 30, 2026, Malaysia’s Medical Device Authority(MDA) issued an announcement introducing a defined validity period for Product Classification Letters, along with changes to how classification applications are submitted and processed. The changes took effect on October 1, 2026. Product Classification Letters are issued through MDA’s Product Classification Application System(PCAS) and ar..

On September 23, 2026, New Zealand's Environmental Protection Authority (EPA) announced that the Government has approved amendments to the Hazardous Substances and New Organisms Act 1996 (the "HSNO Act") to implement restrictions on three new persistent organic pollutants (POPs)—chlorpyrifos, medium-chain chlorinated paraffins (MCCPs), and long-chain perfluorocarboxylic acids, their salts and re..

On September 2026, the Philippine Food and Drug Administration (FDA) released a draft FDA Circular setting out when it will use on-site, remote, or hybrid inspections for regulated health product establishments. The draft is open for public comment until October 26, 2026. The circular does not change product registration requirements. It does affect the local importers and distributors that hold..

On September 24, 2026, the National Medical Products Administration (NMPA) issued a notice seeking public comments on updated chemical identification information for 913 existing cosmetic ingredients. Stakeholders may submit comments through the relevant online platform by November 25, 2026. The update mainly covers CAS numbers, structural formulas, molecular formulas, and molecular weights for ..

On September 2026, Singapore’s Health Sciences Authority (HSA) introduced a Premarket Submission Checklist for medical device registrations filed through SHARE, its online submission portal. The checklist brings together existing requirements from HSA’s GN-15, GN-17 and GN-18 guidance documents in one place. After a grace period ending December 31, 2026, HSA will reject submissions that do not m..

On September 10, 2026, the Ministry of Health (MoH) of Vietnam has issued guidelines regarding the implementation of and instructions for the ASEAN Cosmetic Good Manufacturing Practice (CGMP-ASEAN) principles and standards. The details as are follow:- The Drug Administration of Vietnam(DAV) to organize the implementation, conduct inspections, and issue CGMP compliance certificates.- The CGMP cer..

On September 14, 2026, the Ministry of Food and Drug Safety (MFDS) of the Republic of Korea aims to prescribe detailed matters delegated to subordinate statutes, following the establishment of legal grounds concerning advance reviews of medical device eligibility, designation and demand survey/supply plan establishment for urgently needed medical devices, and the prohibition of medical device re..